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The main goal of this study is to elucidate the mechanisms of the signal transmission for radiation-induced
bystander response. The NF-κB-dependent gene expression of IL8, IL6, PTGS2/COX2, TNF and IL33 in directly
irradiated human skin fibroblasts produced the cytokines and prostaglandin E2 (PGE2) with autocrine/
paracrine functions, which further activated signaling pathways and induced NF-κB-dependent gene
expression in bystander cells. As a result, bystander cells also started expression and production of
interleukin-8, interleukin-6, COX-2-generated PGE2 and interleukin-33 (IL-33) followed by autocrine/
paracrine stimulation of the NF-κB and MAPK pathways. A blockage of IL-33 transmitting functions with
anti-IL-33 monoclonal antibody added into the culture media decreased NF-κB activation in directly
irradiated and bystander cells. On the other hand, the IGF-1-Receptor kinase regulated the PI3K–AKT
pathway in both directly irradiated and bystander fibroblasts. A pronounced and prolonged increase in AKT
activity after irradiation was a characteristic feature of bystander cells. AKT positively regulated IL-33 protein
expression levels. Suppression of the IGF-R1–AKT–IL-33 pathway substantially increased radiation-induced
or TRAIL-induced apoptosis in fibroblasts. Taken together, our results demonstrated the early activation of
NF-κB-dependent gene expression first in directly irradiated and then bystander fibroblasts, the further
modulation of critical proteins, including IL-33, by AKT in bystander cells and late drastic changes in cell
survival and in enhanced sensitivity to TRAIL-induced apoptosis after suppression of the IGF-1R–AKT–IL-33
signaling cascade in both directly irradiated and bystander cells.
© 2010 Elsevier Inc. All rights reserved.
1. Introduction
Ionizing radiation and chemotherapy are two principal therapeutic
modalities used for cancer treatment. Ever since the discovery of the
X-rays, it has always been accepted that the deleterious effects of
ionizing radiation are due to direct damage of DNA. However,
radiation-induced bystander response, which is defined as the
induction of biological effects in cells that are not directly exposed
to ionizing radiation, but in close proximity to cells that are irradiated,
represents a paradigm shift in our understanding of radiobiological
effects of ionizing radiation [1–3]. The most direct approach to
bystander studies, precise α-irradiation of cells using a focused
microbeam, has been successfully applied in numerous studies
performed with the Columbia University charged particle microbeam
[4–6], as well as with focused microbeams in other laboratories [7].
There is also considerable evidence that media from irradiated culture
(after transfer to non-irradiated cells) can induce biological effects in
the latter, suggesting that irradiated cells secreted biologically active
factors [8].
Although bystander effects have been described over the past
decade, the precise mechanisms of these processes remain unclear.
There are at least five aspects of the initiation and development of
bystander response: i) radiation-induced stress reactions of exposed
cells, which could be accompanied by release of pre-existing signal
transmitters with nuclear localization, such as interleukin-1α(IL-1α)
andHigh-mobility groupbox-1 (HMGB1) protein, followedby initiation
of autocrine and paracrine stimulation of cells by these ligands via the
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corresponding receptors [9]; ii) DNA damage induced activation of
ATM-p53 and ATM-NF-κB signaling pathways followed by the stimu-
lation of NF-κB-dependent gene expression, including IL8, TNF, COX2,
iNOS, and production of prostaglandin E2 (PGE2), reactive oxygen
species (ROS) and nitric oxide (NO) [10–12]; iii) the activation and
stimulation of bystander cells via a paracrinemechanismusing cytokine
or growth factor interactions with the correspondent receptors and an
induction of cell signaling pathways and specific gene expression in
bystander cells [6,12]; iv) translocation of ROS and NO from directly
irradiated to bystander cells through gap junction channels with the
secondary damaging effects on themitochondria and DNA in bystander
cells [12]; v) induction of cell survival mechanisms or balancing
between survival and apoptotic signaling at the late stages of bystander
response [1].
The significance of ROS, NO, some cytokines, such as TGFβ and
TNFα, and intercellular gap junctions for mediating bystander effects
was confirmed in numerous studies, reviewed by Hei at al. [1] and
Prise and O'Sullivan [13]. In our previous publications, we discovered
a role for the transcription factor NF-κB, after direct exposure of
human fibroblasts to α-particle irradiation, in the activation of COX2
and iNOS gene expression followed by production and translocation of
ROS and NO into bystander cells [6,12]. A recent investigation of
global gene expression in directly irradiated and bystander cells
further revealed transcription factor NF-κB as the dominant signaling
hub in bystander response [14,15], and introduced additional players,
which have been investigated in the present study. These include NF-
κB-dependent cytokines, IL-6 and IL-8 [16], and cytokines that induce
the NF-κB signaling pathway via paracrine or autocrine mechanisms
(IL-1β, TNFα and IL-33) [11,17] in concert with receptor tyrosine
kinase activities that control the PI3K–AKT and the MAPK pathways
[18,19]. The main aim of the present study was to elucidate IL33
(interleukin-33) gene expression in human skin fibroblasts and the
role of the IL-33–IL-33R/ST2–NF-κB and IGF-1R–PI3K–AKT–IL-33
signaling pathways in mediating bystander responses, including
effects on cell survival and apoptosis. Our results indicated that IL33
expression played an important role in radiation-induced bystander
effects via NF-κB-dependent regulation of expression of numerous
genes, including several cytokines and COX2. However, in addition to
damaging effects mediated by NF-κB-dependent COX-2–PGE2 and
iNOS–NO expression, NF-κB-dependent expression of IL-33 controlled
cell survival functions, balancing between cell life and death [20].
2. Materials and methods
2.1. Materials
Human Killer-TRAIL was purchased from Axxora (San Diego, CA,
USA). PI3K inhibitor LY294002, IKK inhibitor BMS-345541, ATM
inhibitor KU55933 and IGF-1 receptor inhibitor picropodopyllin (PPP)
were purchased from Calbiochem/EMD Chemicals (San Diego, CA,
USA). Insulin-like growth factor binding protein-3 (IGFBP-3) was
obtained from Sigma (St. Louis, MO, USA).
2.2. Cell culture
Human skin fibroblasts (HSF) immortalized by SV40 T-antigen [12]
weremaintained in a 4.5 g/l glucose DMEMwith 4 mML-glutamine and
100 mg/l sodium pyruvate supplemented with 10% fetal bovine serum,
100 IU/ml penicillin, and 100 μg/ml streptomycin. Suppression of p53
downstream activities, which were non-essential for bystander re-
sponse [21], by SV40 T-antigen allowed us to simplify the further
analysis of gene expression that controls the development of bystander
response in HSF. Normal human lung fibroblasts, IMR-90 (Coriell Cell
Repository, Camden, NY, USA), were maintained in DMEM supplemen-
tedwith 15% fetal bovine serum, antibiotics, vitamins and non-essential
amino acids (Invitrogen, Carlsbad, CA, USA).
2.3. Irradiation procedure
The strip mylar dishes were used in the present studies as described
[6]. Exponentially growing HSF was plated in the concentric strip mylar
dishes two days before irradiation to ensure a confluent state. A 50 cGy
dose of
4
He ions (120 keV/μm)was delivered to the cells using the track
segment irradiation facility of the 5.5-MV Singletron accelerator at the
Radiological Research Accelerator Facility of Columbia University. After
irradiation, at selected time points, the inner and outer mylar dishes
were separated and the cells fromeach growth surfacewere trypsinized
and individually pooled for endpoint analysis.
2.4. Survival of irradiated and non-irradiated cells
Non-irradiated control cells,α-irradiated and bystander cells were
collected 24 h after irradiation. Cultures were trypsinized, counted
with a Coulter counter, and aliquots of the cellswere replated into 100-
mm-diameter dishes for colony formation. Cultures for clonogenic
survival assayswere incubated for 12 days, atwhich time theywerefixed
with formaldehydeand stainedwithGiemsa. Thenumberof colonieswas
counted to determine the surviving fraction as described [4].
2.5. RNA isolation
Directly irradiated (outerdish) andbystander (inner dish) cellswere
separated at specified times after irradiation andRNAwas isolatedusing
Ribopure (Applied Biosytems, Foster City, CA). RNA concentration was
measured using a NanoDrop-1000 spectrophotometer (Thermo Scien-
tific, Waltham, MA) and RNA quality was monitored with the Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).
2.6. Quantitative real time PCR (qRT-PCR)
The High-Capacity cDNA Archive Kit (Applied Biosystems) was
used to prepare cDNA from total RNA. A custom low-density TaqMan
array was designed with validated assays and obtained from Applied
Biosystems as previously described [15]. For gene validation studies,
100 ng cDNA was used as input for low-density arrays. qRT-PCR
reactions were performed with the ABI 7900 real time PCR System
using Universal PCR Master Mix (Applied Biosystems) with initial
activation at 50 °C for 120 s and 94.5 °C for 10 min followed by
40 cycles of 97 °C for 30 s and 59.7 °C for 60 s. Individual TaqMan
assays for IL33 (Hs00369211_m1), IGF1R (Hs00951562_m1) and
IGFBP3 (Hs00426287_m1) were pre-made and validated assays from
Applied Biosystems. Input cDNA was set at 10 ng for all samples and
genes, except IL33, which required 100 ng input, and qRT-PCR
reactions were performed with the ABI 7900 real time PCR System
using Universal PCR Master Mix from Applied Biosystems. All single
gene assays were run in duplicate reactions. Relative fold-inductions
were calculated by the ΔΔCTmethod as previously used [22] and with
SDS version 2.3 software (Applied Biosystems). We measured 7
housekeeping genes on the low-density arrays and applied Genorm
[23] to determine the most appropriate genes for normalizing the
results. Both the low-density array data and the individual gene
assays were normalized to Ubiquitin C (UBC).
2.7. FACS analysis of DR5 surface levels
Surface levels of DR5 were determined by staining with the PE-
labeledmAb fromeBioscience (SanDiego, CA, USA). A FACS Caliburflow
cytometer (Becton Dickinson, Mountain View, CA, USA) combinedwith
the CellQuest program was used to perform flow cytometric analysis.
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2.8. Apoptosis studies
Cells were exposed to soluble TRAIL (50 ng/ml) alone or in
combination with cycloheximide (2 μg/ml). Different variants of
combined treatment were used, including α-irradiation (0.5 Gy)
followed by TRAIL treatment. Apoptosis was then assessed by
quantifying the percentage of hypodiploid nuclei using FACS analysis.
2.9. Western blot analysis
Total cell lysates (50 μg protein) were resolved on SDS-PAGE, and
processed according to standard protocols. The monoclonal antibodies
used for Western blotting included: anti-β-Actin (Sigma, St. Louis, MO,
USA); anti-FLIP (NF6) (Axxora); anti-ATM(D2E2) andanti-phospho-ATM
(Ser1981); anti-phospho-p53 (Ser15); anti-Smac/Diablo; anti-basic FGF;
anti-GSK-3β (Cell Signaling, Beverly, MA, USA); anti-XIAP (clone 48) BD
Biosciences (SanDiego, CA,USA); anti-IL33(ProSci, Poway,CA,USA); anti-
IL8 (R&D Systems, Minneapolis, MN, USA). The polyclonal antibodies
used included: anti-DR5 (Axxora); anti-phospho-p53 (Ser20), and anti-
total p53; anti-phospho-SAPK/JNK (Thr183/Tyr185) and anti-JNK; anti-
phospho-p44/p42 MAP kinase (Thr202/Tyr204) and anti-p44/p42 MAP
kinase; anti-phospho-AKT (Ser473) and anti-AKT; anti-phospho-IGF-1
receptor (Tyr1135/1136) and anti-IGF-1 receptor β; anti-β-Catenin; anti-
Phospho-GSK-3β; anti-FOXO3A (Cell Signaling). The secondary Abs was
conjugated to horseradish peroxidase; signals were detected using the
ECL system (Thermo Scientific, Rockford, IL, USA).
2.10. EMSA
Electrophoretic mobility shift assay (EMSA) was performed for the
detection of NF-κB DNA-binding activity as previously described [24].
Ubiquitous NF-Y DNA-binding activity was used as an internal control.
Furthermore, Western blot analysis followed by densitometric
analysis of IκBα, an inhibitor of NF-κB, and β-actin levels was
performed. Background corrected IκBα intensity measurements were
normalized to β-actin protein levels.
2.11. Statistical analysis
Data of 3-4 independent experiments were calculated asmeans and
standard deviationsScheme 1. Comparisons of results between treated
and control groupsweremade by the Students' t-tests. A P-value of 0.05
or less between groups was considered significant.
3. Results
3.1. Signaling pathways in directly α-irradiated and bystander fibroblasts
Ionizing radiation induces and accelerates numerous signaling path-
ways, some of which are initiated in the nucleus due to DNA damage,
including two master signaling pathways, ATM-p53 and ATM-NF-κB
[10,25,26]. Other signaling pathways are started at the cell surface by a
ligand-receptor interaction, suchas IGF-1/IGF-1Ror FGF2/FGF-R, followed
by activation of growth factor receptor tyrosine kinases [19,27]. A direct
modification of p53 via ATM-dependent phosphorylation of p53-Ser15, a
characteristic feature of ATM activation, was observed 1h afterα-particle
irradiation of human skin fibroblasts (HSF), but no accompanying
stabilization and accumulation of p53 protein (Fig. 1A), consistent with
the presence of SV40 T-antigen used for immortalization of these cells
[12]. Correspondingly, p53-dependent gene expression, such as CDKN1A/
p21, and p53-dependent downstream pathways was mostly blocked in
these fibroblasts (Fig. 1C and data not shown).GADD45A gene expression
that could be p53-dependent or p53-independent [28] demonstrated
modest activation in both directly irradiated and bystander cells (Fig. 1C).
Since the p53 downstream pathway was not essential for induction of
bystander response [15,21], our cell model allowed us to focus on other
crucial genes controlling the development of bystander response,
especially, on gene expression regulated by transcription factor NF-κB.
Up-regulation of nuclear NF-κB p65-p50 activity (determined by EMSA)
that was accompanied by IκBα degradation (determined by Western)
was detectable in irradiated fibroblasts 1h after treatment and then in
both directly irradiated and bystander cells 4h after treatment, indicating
an induction of bystander signaling (Fig. 1B). PTGS2/COX2 gene
expression, a classical target of NF-κB, rapidly increased after irradiation
in both directly exposed and bystander HSF (Fig. 1C).
Furthermore,α-irradiationwas linkedwith activation of theMAPK
pathways and the PI3K–AKT pathway in exposed cells. The MEK-
ERK1/2 pathway was substantially upregulated in both directly
irradiated and bystander HSF 1–4 h after treatment (Fig. 1A); while
two other MAPK's, JNK and p38, did not exhibit notable levels of
phosphorylation in HSF (data not shown). Surprisingly, a significant
increase in levels of active form phospho-AKT (S473) 1–4 h after
irradiation was characteristic of bystander, but not directly irradiated
HSF, which demonstrated more modest increase in AKT phosphory-
lation (Fig. 1A; see also Fig. 5A).
Strong up-regulation of ERK1/2 activities was also observed in
directly irradiated and bystander human lung fibroblasts, IMR-90.
Similarly with HSF, pronounced AKT phosphorylation was a charac-
teristic feature of bystander IMR-90 fibroblasts (Fig. 1D). Up-
regulation of NF-κB activity (determined by a notable decrease in
IκBα levels) and NF-κB-dependent gene expression of PTGS2/COX2
[15], IL1B and IL33 were also observed in both directly irradiated and
bystander IMR-90 cells (Fig. 1D and E), highlighting a role for NF-κB
transcriptional targets in bystander response.
3.2. A role of ATM for regulation of bystander response
Sixteen hours after α-particle irradiation, ATM activation via
autophosphorylation was observed in both directly irradiated and
bystander fibroblasts (Fig. 2A). As we mentioned, two characteristic
downstream targets of the ATM signaling pathway initiated by DNA
damage are transcription factors p53 and NF-κB [10,25,29]. Using the
specific pharmacological inhibitor of ATM autophosphorylation and
activation, KU55933 (10 μM), we demonstrated effects of ATM
inhibition on both p53- and NF-κB-signaling pathways: i) suppression
or down-regulation of ATM-dependent Ser15 and Ser20 phosphory-
lation of p53 (Fig. 2A and data not shown) and ii) down-regulation of
the nuclear NF-κB DNA-binding activity in both directly irradiated and
bystander HSF (Fig. 2A). These data established a dependence of NF-
κB activation on ATM in HSF. Since ATM was involved in the
regulation of the cell cycle and radiation-induced apoptosis, suppres-
sion of its activity by KU55933 drastically changed cell cycle profiles
by up-regulating apoptotic levels in directly irradiated HSF and
increasing levels of G2/M arrest for bystander cells (Fig. 2B).
Furthermore, clonogenic survival assay revealed a dramatic decrease
in general cell survival of directly irradiated HSF and notable decrease
in survival of bystander fibroblasts in the presence of KU55933
(Fig. 2C). Taken together, results obtained confirmed a general
regulatory function of ATM for both radioprotection and radiation-
induced bystander response of HSF.
3.3. Cytokine gene expression in directly irradiated and bystander HSF
Within 0.5–1 h of irradiation, mRNA levels of the known NF-κB
transcriptional targets PTGS2/COX2 and IL8, started to increase
(Figs. 1D and 3A and B) in directly hit and bystander cells. A
substantial up-regulation of IL-8 (Fig. 4A) and COX-2 [12] protein
expression also occurred in bystander cells 4 h after treatment
highlighting the generation of bystander response. The increase in
IL8mRNA levels preceded the corresponding change in protein levels
in irradiated and bystander cells (Figs. 3B, and 4A).
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Additional NF-κB gene targets and some other genes identified in a
prior global analysis of gene expression in directly irradiated and
bystander IMR-90 fibroblasts [15] were screened for radiation and
bystander response in HSF cells (Fig. 3A). Besides IL8, the NF-κB targets
IL1A (interleukin-1A), IL1B and MMP3 (matrix metallopeptidase 3) also
exhibited early increases in gene expression, while SOD2 (superoxide
dismutase 2) was upregulated 4 h and IL6 — 24 h after irradiation
(Fig. 3A, B). Although IL33, a recently discovered member of the IL-1
cytokine family and a potential NF-κB target [20,30], was transcribed at
relatively low levels in HSF, its expression increased in both directly
irradiated and bystander cells, modestly at 1–4 h after irradiation and
pronouncedly by 24 h (Fig. 3A and C). Western blot analysis revealed
increased protein levels of IL-33 (MW 31 kD) in bystander HSF 4 h
after irradiation (Fig. 4A). Pronounced upregulation of IL33 and IL1B
gene expression was also observed in directly irradiated and bystander
IMR-90 cells (Fig. 1E).
On the other hand, endogenous TNFα protein (precursor form of
26 kD) was present at relatively high levels in both irradiated and
bystander cells 1–4 h after treatment (Fig. 4A). A role for TNFα in the
generation of ROS and regulation of bystander response was
previously described [6,12]. Skin fibroblasts are known to express
receptors for IL-1, IL-6, IL-8 and IL-33, as well as TNF-R1 [31,32].
Hence, our observations allowed us to consider cytokines IL-1α, IL-1β,
IL-6, IL-8 and IL-33, in concert with TNFα, as potential intercellular
signal transmitters following α-particle irradiation.
IL-33 is a known activator of the NF-κB signaling pathway upon its
interaction with the specific IL-33-receptor/ST2 [17]. To confirm IL-
33-dependent NF-κB activation in HSF, we added the inhibitory anti-
IL-33 mAb (2 μg/ml) to the cell culture media 1 h before irradiation.
This notably decreased the nuclear basal and inducible NF-κB DNA-
binding activities determined by EMSA in both directly exposed and
bystander cells 2 h after treatment (Fig. 4B). Simultaneously, protein
levels of COX-2, a classical NF-κB target, were also decreased in the
cytoplasmic fraction of cells (Fig. 4B) indicating a dependence of COX-
2 expression levels on the IL-33–NF-κB pathway in HSF. We
previously observed regulation of COX-2 expression via the TNFα–
NF-κB pathway [12]. Taken together, our data demonstrated that both
cytokines IL-33 and TNFα are involved in activation of the NF-κB
Fig. 1. The main signaling pathways induced in directly irradiated and bystander fibroblasts. (A, B) Expression levels of indicated proteins from the control, bystander and α-
irradiated human skin fibroblasts (HSF) were determined 1 and 4 h after treatment by Western blot analysis (W). EMSA (E) was performed for determination of DNA-binding
activity of nuclear NF-κB and NF-Y transcription factors. Two main NF-κB DNA-binding complexes are indicated. Ubiquitous NF-Y activity was used as an internal control of the
nuclear protein loading. Position of the free labeled probe (FP) is indicated. (C) Time course of gene expression of CDKN1A/p21, GADD45A and PTGS2/COX2 in directly irradiated (IR)
and bystander cells (BY) at 0.5, 1, 4, and 24 h after irradiation, was determined by quantitative real time PCR and normalized to Ubiquitin C (UBC). Values are relative to time-matched
controls (solid line at 1). Points are the mean and standard error of three independent experiments. (D) Western blot analysis of indicated proteins from the control, bystander and
α-irradiated IMR-90, human lung fibroblasts. (E) Time course of gene expression of IL1B and IL33 in directly irradiated and bystander IMR-90 fibroblasts.
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signaling pathway in HSF, which is also under general control of the
nuclear ATM activity (see Fig. 2).
3.4. Growth factors and growth factor receptors expression in HSF
Another NF-κB target gene, FGF2, encoding fibroblast growth
factor-2, demonstrated relatively modest changes in kinetics of
transcription after irradiation of fibroblasts (Fig. 3C). FGF2 protein
levels were easily detectable in non-treated control cells and were
additionally increased 1 h after irradiation. FGF-receptor-1 protein
expression, however, was not detectable in either control or treated
HSF (data not shown). This means that FGF2 was probably not a
player in radiation-induced autocrine/paracrine stimulation in human
skin fibroblasts, although it was involved in paracrine stimulation of
melanocyte and melanoblast proliferation in vivo [33].
Endogenous IGF-1 (insulin-like growth factor-1) gene expression
was detected at low levels and did not notably change following
irradiation of HSF (data not shown). However, exogenous IGF-1
Fig. 2. The ATM signaling pathway induced NF-κB activation in directly irradiated and bystander human skin fibroblasts. (A) Expression levels of total and phosphorylated ATM and
p53 from the control, bystander and α-irradiated human skin fibroblasts were determined 4 h after treatment by Western blot analysis. KU55933 (10 μM), a pharmacological
inhibitor of ATM activity, was added 30 min before α-irradiation (0.5 Gy). EMSA was performed for determination of DNA-binding activity of nuclear NF-κB and NF-Y. (B) Cell cycle-
apoptosis analysis of control non-irradiated, directly irradiated and bystander cells 48 h after treatment using PI staining of DNA and FACS analysis. Results of a typical experiment
(one from four) are shown. KU55933 was added 30 min before α-irradiation. (C) Clonogenic survival assay of human skin fibroblasts (control, α-irradiated and bystander) 12 days
after treatment in the presence or absence of KU55933. Error bars represent mean±S.D. from four independent experiments.
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protein was a constitutive component of the HSF cell media. IGF-1R
(insulin-like growth factor-1 receptor) mRNA and protein levels
showed a modest and transient increase in expression 1 h after
irradiation. At later time points, IGF-1R mRNA and total protein
levels were relatively stable with high content of the active
phosphorylated form, IGF-1Rβ-P (Y1135) (Figs. 3C and 4C). This
suggests that IGF-1/IGF-1R interaction might be permanently
involved in the regulation of cell signaling cascades in both control
and exposed HSF.
3.5. IGF-R–AKT–β-catenin and AKT-mTOR axes in HSF
The IGF-1R-kinase activation was accompanied by upregulation of
AKT activity that was still detected at higher levels in bystander cells
16 h after irradiation (Fig. 4C). A pronounced decrease in the
endogenous insulin-like growth factor binding protein-3 (IGFBP-3)
levels, an upstream regulator of IGF-mediated signaling, might be a
reason for upregulation of AKT activity in bystander cells (Fig. 4C).
AKT inactivated GSK3β via Ser9-phosphorylation in bystander cells
that was followed by notable up-regulation of β-catenin protein
levels, due to β-catenin stabilization (Fig. 4C) [34]. Stabilization of β-
catenin favors its nuclear translocation, leading to positive effects on
transcriptional regulation (in complex with LEF1) of targets such as
PTGS2/COX2 [12,35].
Another established axis of the AKT signaling pathway, mTOR
phosphorylation and activation, was substantially upregulated in
bystander HSF 16 h after treatment (Fig. 4C). Taken together, these
observations highlighted activation of the AKT signaling pathway and
its pronounced effects on the classical targets in bystander fibroblasts.
3.6. Pro-survival role for the AKT pathway and IL-33 expression in
bystander fibroblasts
To further confirm the major role of IGF1-R-mediated signaling in
the activation of the downstream AKT signaling pathway in HSF, we
used picropodophyllin (PPP), a specific inhibitor of IGF1-R-mediated
signaling that blocks the critical Tyr1135 autophosphorylation [36]
and LY294002, an inhibitor of the PI3K-like kinases and PI3K–AKT
pathway. Treatment with PPP (0.5 μM) caused only a slight decrease
in non-target phospho-(Y1131)-IGF-1R levels, but a strong decrease
in phospho-(Y1135/Y1136)-IGF1R levels, which are crucial for kinase
activity (Fig. 5A). A minor basal activity was only detected in control
cells (Fig. 5A) disappearing at increased dose of PPP (1.0 μM) (data
not shown). PPP at 0.5 μM completely blocked basal and inducible
AKT phosphorylation in both bystander and irradiated cells (Fig. 5A).
Fig. 3. Relative gene expression in α-irradiated and bystander HSF 0.5-24 h after treatment. (A) Heatmap of gene expression levels across the time course of 0.5, 1, 4 and 24 h in
directly irradiated and bystander cells as measured by low-density qPCR array. (B) Expression of IL8, MMP3 and IL6 in HSF in directly irradiated (red triangles) and bystander cells
(blue triangles) at 0.5, 1, 4, and 24 h after irradiation, relative to time-matched controls and normalized to UBC. Gene expression was determined by quantitative real time PCR.
(C) Relative gene expression changes in IL33, FGF2 and IGF-R1 were determined by quantitative real time PCR.
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Furthermore, PPP decreased levels of ERK1/2 phosphorylation, but
only in directly irradiated cells, while strongly increasing phosho-
ERK1/2 levels in control cells (Fig. 5A). Mutual antagonism between
ERK and AKT activation could be partially responsible for such
regulation [37].
On the other hand, LY294002 (50 μM) modestly decreased the
basal levels of AKT phosphorylation and abolished inducible phos-
phorylation in both bystander and irradiated cells (data not shown).
This suggested that regulation of the basal and inducible AKT activity
based on different mechanisms in HSF. Furthermore, there was no
linear correlation between IGF-1R kinase activity and activation of
AKT in distinct fibroblast types (control, irradiated and bystander). It
suggested that additional modulation, for example, either by PTEN or
IGFBP-3 binding activity might finally determine levels of AKT
activation in bystander and irradiated fibroblasts. IL-33 expression
was also substantially suppressed by LY294002 (50 μM) and com-
pletely blocked by PPP (0.5 μM) in bystander and irradiated cells, but
incompletely in the control cells (Fig. 5A). Hence, IGF-1R-dependent
AKT signaling was involved in regulation of IL-33 expression levels in
both irradiated and bystander fibroblasts (Fig. 5A). This signaling
pathway was necessary, but not sufficient for the full control of IL-33
expression, which demonstrated only partial correlationwith levels of
AKT activation (Fig. 5A).
Treatment of HSF with PPP also resulted in a dose-dependent G2/
M arrest (Fig. 5B), which was further accompanied by slow cell death,
presumably by necrosis, based on the results of clonogenic survival
analysis (Fig. 5C). However, combined treatment by PPP (0.5 μM) and
α-irradiation (0.5 Gy) caused an up-regulation of apoptotic levels that
were especially high in bystander cells (Fig. 6A), demonstrating a
strong blockage of general survival functions in these cells. Pretreat-
ment with the inhibitory anti-IL-33 mAb (2 μg/ml in the cell media),
but not with non-specific IgG, also increased apoptotic levels in both
directly irradiated and bystander cells, although this effect was less
pronounced than that of PPP treatment (Fig. 6A).
3.7. Suppression of IGF-1R–IL-33 increased TRAIL-mediated apoptosis
In spite of the blockade of the p53 downstream signaling (which
positively regulates DR5 transcription), TRAIL–R2/DR5 expression was
detected at average levels in human skin fibroblasts (Fig. 6B).
Furthermore, total and surface expression of DR5 protein further
increased upon irradiation (Fig. 6C). The total intracellular level of
DR5 increased also in bystander cells; however, death receptor
protein was not effectively translocated to the surface of bystander
cells (Fig. 6C). Expression levels of the anti-apoptotic proteins cFLIP-L
and XIAP were modestly higher in bystander cells than in directly
Fig. 4. Protein expression levels of human skin fibroblasts following α-irradiation. (A) Western blot analysis of intracellular levels of indicated cytokines 1–4 h after α-irradiation.
Actin was used as a protein loading control. Ratios of IL8/Actin and IL33/Actin are indicated. (B) EMSA for determination of nuclear NF-κB DNA-binding activity. Non-specific IgG or
anti-IL33 mAb (2 μg/ml) were introduced into the cell media 1 h before α-irradiation. Nuclear and cytoplasmic proteins were isolated from HSF 2 h after treatment. Nuclear protein
was used for EMSA while cytoplasmic protein was used for detection of COX-2 and Actin by Western blot analysis. The p65-p50 NF-κB/NF-Y ratio and the COX-2/Actin ratio are
indicated. (C) Western blot analysis of indicated proteins from human skin fibroblasts 16 h after treatment.
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irradiated cells (Fig. 6B). Exogenous TRAIL (50 ng/ml) induced
apoptosis in skin fibroblasts, which was especially high in combina-
tion with ionizing radiation (0.5 Gy) (Fig. 6A). Pretreatment with
inhibitory anti-IL-33 mAb that partially suppressed the nuclear NF-κB
activity (Fig. 4B) additionally increased TRAIL-mediated apoptosis in
the control, directly irradiated and bystander fibroblasts (Fig. 6A). As
expected, pretreatment with PPP (0.5 μM) demonstratedmore drastic
effects on up-regulation of TRAIL-mediated apoptosis in the control,
bystander and directly irradiated cells (Fig. 6A), due to its strong
inhibition of the AKT survival pathway by PPP (Fig. 5A). These data
further confirmed a general dependence of the resistance to TRAIL-
mediated apoptosis on IGF-1R–AKT–IL-33-mediated protective func-
tions in control, irradiated and bystander skin fibroblasts.
3.8. A role for exogenous IGFBP-3 in regulation of AKT activation and
TRAIL-induced apoptosis in HSF
To further elucidate a role for natural physiological regulators, such as
insulin-like growth factor bindingprotein-3, IGFBP-3 [38], in the control of
IGF-1R-mediated signaling, AKT activation and TRAIL-mediated apoptosis
in HSF, we used exogenous IGFBP-3 (100 ng/ml in the cell media) that
reversibly binds IGF-1, presumably decreasing the current levels of
activation of IGF-1R-mediated signaling, but extending the duration of its
action (due to increased stability of IGF-1 in complex with IGFBP-3).
Finally, after 24 h incubation in the presence of IGFBP-3, we observed
upregulation of the basal AKT activity, AKT-dependent phosphorylation
and inactivation of GSK3β followed by decreased phosphorylation of β-
catenin and the stabilization of β-catenin protein levels in the control and
directly irradiated cells. No additional effects of IGFBP-3were detected on
already high levels of AKT activity in bystander fibroblasts 24 h after
treatment (Fig. 7A). In general, these data suggested a preferential role of
exogenous IGFBP-3 for functional extension of IGF-1R-mediated signaling
in HSF. It was opposite to a negative role of the endogenous IGFBP-3 for
down-regulation of AKT activity (see Fig. 4C). Levels of p53 and p53-
dependent BAXwere stable in this cell model before and after treatment,
as expected (Fig. 7A). A physiological consequence of the exogenous
IGFBP-3-induced upregulation of the AKT–β-catenin pathway was a
decrease in levels of TRAIL-mediated apoptosis, especially in directly
irradiated cells (Fig. 7B and C). It further suggested a critical role of AKT
activity and, probably, AKT–β-catenin-dependent targets, in the attenu-
ation of TRAIL-mediated apoptosis [39] in transformed human skin
fibroblasts.
4. Discussion
The main cell model used in the present investigation is human
skin fibroblasts (HSF) immortalized by SV40 T-antigen with sup-
pressed p53-dependent functions. This cell model is characterized by
features, such as blocked senescence and p53-mediated apoptosis
that are common in both transformed cells and embryonic stem cells,
as well as in induced pluripotent stem (iPS) cells [40]. Simultaneously,
this cell model was suitable for studying bystander effects, due to
independence of bystander response from p53 activation [1,15,21].
Our previous investigations, which were performed using these cells,
demonstrated an important role of mitochondria in radiation-induced
bystander effects through mitochondria-dependent regulation of the
NF-κB–COX-2 and the NF-κB–iNOS pathways [12]. Suppression of NF-
κB activation drastically decreased bystander response in HSF. Our
next task was determining effects of the α-irradiation-induced gene
expression (with special attention to NF-κB-mediated transcription)
on the synthesis and secretion of signal transmitters that could initiate
the secondary bystander signaling pathways in human fibroblasts.
Fig. 8 summarizes our experimental data and demonstrates a
unified current model of the bystander signaling pathways
Fig. 5. Effects of suppression of IGF-R1-mediated signaling pathway on AKT and ERK activation and apoptosis of HSF. (A)Western blot analysis of indicated proteins from HSF, which
were irradiated in the presence and absence of PPP (0.5 μM). Actin was used as a protein loading control. (B) G2/M arrest of the cell cycle following PPP (0.25–1.0 μM) treatment of
HSF. (C) Clonogenic survival assay of HSF 12 days after indicated treatment with PPP.
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determined in our studies for factors transmitted through cell media.
Technically, we could not detect gap junction translocation from
directly irradiated to bystander cells in this type of experimental
model. Since activation of the ATM-p53 and ATM-NF-κB pathways
with the subsequent up-regulation of expression of the p53- and NF-
κB-regulated genes is hallmark of the cell radiation response [10,25],
we determined expression levels and activation of signaling proteins
from these cascades in directly α-irradiated and bystander human
skin fibroblasts (HSF) at early and late time points after irradiation
and monitored the development of bystander effects. We confirmed
previously reported data on the general significance of ATM in
bystander response [41] using our cell system. Since the downstream
p53 signaling pathways were suppressed in the SV40 T-antigen
immortalized HSF, the NF-κB-dependent pathway appears to be the
main regulator of radiation-induced gene expression. An additional
possibility for “immediate early” activation of this pathway might be
linked with pre-existing IL-33 that together with IL-1α and HMGB1
play a role as “alarmins”, signaling proteins that are released by cells
upon stress conditions or cell damage and may initiate both cell
survival (using the IL-33-R/ST2-NF-κB loop) or cell death signaling
[9,30]. Hence, IL-33–IL-33R/ST2 via activation of the NF-κB pathway
may control IL8, COX2, iNOS and, probably, its own expression, which
is also dependent on AKT activation (see Fig. 5). Besides IL-33, several
cytokines, such as TNFα and IL-1β, are known, to be inducers of the
NF-κB signaling pathway [42]. A pronounced inhibition of NF-κB
signaling and NF-κB-dependent proteins (such as COX-2) by the
inhibitory anti-IL-33 mAb added to the cell media (Fig. 4B) demon-
strated a role for IL-33 in the paracrine/autocrine NF-κB stimulation
after irradiation of human skin fibroblasts. Upregulation of NF-κB-
dependent IL1B and IL33 gene expression was also demonstrated in
directly irradiated and bystander IMR-90, human lung fibroblasts (see
Fig. 1E). Taken together, our results indicated that the primary ATM-
NF-κB signaling pathway was tightly linked with gene expression and
secretion of pro-inflammatory cytokines, IL-1β, IL-6 and IL-8, a
characteristic feature of persistent DNA damage signaling [43], as
well as with IL-33, a recently discovered member of the IL-1 family
(see also Fig. 8 with general signaling pathways). These cytokinesmay
initiate the secondary activation of cell signaling pathways, including
the NF-κB pathway, via autocrine/paracrine mechanisms. To our
knowledge, this is the first demonstration of the role of IL-33 in
bystander response.
Positive regulation of the IGF1-R–PI3K–AKT signaling pathway in
bystander HSF and IMR-90 cells that was revealed in the present study
appears to be one of the critical features of bystander response. An up-
regulation of AKT activation in bystander cells might be directly linked
with down-regulation of PTEN activity, the main negative regulator of
the PI3K–AKT pathway. It is well known that PTEN is one of the main
targets of reactive oxygen species (ROS), which could oxidize and
inactivate this phosphatase [44] resulting in activation or up-
regulation of the AKT pathway. An additional possibility for
suppression of PTEN is dependent on NF-κB activation [45]. A typical
downstream effect of the AKT signaling pathway, inactivation of
Fig. 6. Regulation of apoptosis in HSF. (A) Pretreatment with PPP or anti-IL-33 mAb increased radiation-induced or TRAIL-induced apoptosis levels in directly exposed or bystander
cells. Apoptosis was induced by TRAIL (50 ng/ml) and cycloheximide (CHX, 2 μg/ml) in control, directly irradiated and bystander cells pretreated with non-specific IgG, anti-IL-33
(2 μg/ml) mAb or PPP (0.5 μM). Apoptotic levels were determined using PI staining of DNA and FACS analysis. (B) Western blot analysis of indicated proteins from control, directly
irradiated and bystander cells. FOXO3A levels were used as protein loading controls. (C) Surface expression of TRAIL-R2/DR5 was determined using immuno-staining and FACS
analysis of control, α-irradiated and bystander HSF 16 h after treatment.
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GSK3β by AKT-dependent phosphorylation and the subsequent
stabilization of β-catenin protein levels [34], was also observed in
bystander cells and appeared to be important for the development of
bystander response, for example via further activation of COX2 gene
expression by β-catenin-LEF1 [35].
An additional level of regulation of the IGF-1R–PI3K–AKT pathway
might be provided by IGFBP-3 [38]. The endogenous IGFBP-3 protein
levels were decreased in bystander fibroblasts, and this was
accompanied by a corresponding increase in AKT activation in these
cells. Based on these observations, we further elucidated the effects of
exogenous IGFBP-3 (added to the culture media) on cell signaling and
apoptosis. IGFBP-3 is the major member of the insulin-like growth
factor binding protein family. The protein forms a ternary complex
with either IGF-1 or IGF-2. Such relations, prolonging the half-life of
IGFs and altering their interaction with cell surface receptors may
have very different effects on acute and continuous responses induced
by IGF in target cells [27,38]. Surprisingly, exogenous IGFBP-3
(100 ng/ml) actually upregulated the AKT–GSK3β−β-catenin path-
way in control and directly irradiated HSF after prolonged exposure
(Fig. 7A). Subsequently, due to up-regulation of AKT activity, IGFBP-3
down-regulated TRAIL-mediated apoptosis levels in both irradiated
and bystander HSF 24–48 h after treatment (Fig. 7B and C). In contrast
to these observations, IGFBP-3 was previously described as an
accelerator of TRAIL-mediated apoptosis in some human cancer cell
lines [46]. If effects of IGFBP-3 are quite different in normal and cancer
cells, it will allow us to use IGFBP-3 for attenuation of apoptotic
signaling in normal cells during anti-cancer therapy. This hypothesis
is under active investigation in our laboratory using human primary
cell cultures and human cancer cell lines. The important task is to find
differences in the IGFBP-3-dependent signaling pathways in normal
and cancer cells.
Taken together, results of the present study demonstrated the
early activation of NF-κB-dependent gene expression (such as IL8,
MMP3 and PTGS2/COX2) in directly irradiated and bystander cells and
the further modulation of critical protein levels, including IL-33, by
the IGF1-R–PI3K–AKT pathway in bystander cells (see Fig. 8). IL-33
Fig. 7. Effects of exogenous IGFBP-3 on cell signaling and TRAIL-mediated apoptosis in HSF. (A) Effects of IGFBP-3 (100 ng/ml in the cell media) on the AKT-dependent pathway, as
well as on p53 and BAX in non-irradiated, irradiated and bystander cells were determined by Western blot analysis 24 h after treatment. (B, C) Effects of IGFBP-3 (100 ng/ml) on
TRAIL-induced apoptosis in directly irradiated and bystander cells. Apoptotic levels were determined 48 h after treatment using PI staining of DNA and FACS analysis. Typical data are
shown in B; Error bars represent mean±S.D. from three independent experiments shown in C.
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plays an important role for NF-κB activation in bystander cells,
probably via autocrine/paracrine interaction with the IL-33R/ST2L,
TRAF6 and IRAK complex [47]. Suppression of IL-33 expression, as
well as suppression of its upstream regulator PI3K–AKT, was followed
by late drastic changes in cell survival and an increase in TRAIL-
mediated apoptosis in both directly irradiated and bystander human
skin fibroblasts.
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